Business
"MarketWatch" Features Halberd Corporation With Prominent Pharmaceutical Companies on New Treatments for COVID-19
"MarketWatch" Features Halberd Corporation With Prominent Pharmaceutical Companies on New Treatments for COVID-19.
About this update from Halberd Corp.
[{"type":"text","content":"JACKSON CENTER, PA / ACCESSWIRE / May 19, 2021 / Halberd Corporation (OTC PINK:HALB) was featured in a recent MarketWatch article, "New Approaches to Covid-19 Treatment Enter the Picture," along with six other notable biotechnology companies. As stated in the article, "The Covid-19 treatment response process includes a number of different major players, including Pfizer Inc (PFE), BioNTech SE - ADR (BNTX), Moderna Inc (MRNA), AstraZeneca plc (NAZN), Novavax Inc (NVAX), Halberd Corp (OTC PINK:HALB), and Johnson & Johnson (JNJ)."The article goes on to recognize Halberd for its innovative approach - using radio waves or laser emissive energy, extracorporeally, to eradicate the SARS-CoV-2 virus from bodily fluids, stating, "The company [Halberd] may be one of the few that has the capacity to offer something materially different to the established paradigm."William A. Hartman, Chairman, President & CEO of Halberd Corporation, stated, "We are proud to be included in this auspicious group of Covid-19 technology leaders. While we do not know whether any of the other companies mentioned in the article paid for their inclusion in it, Halberd Corporation did not. A careful analysis of the article and the relative contributions of each mentioned company reveals that what Halberd has is clearly the most unique and most susceptible to sustainable universal disease treatment, and thus useful beyond Covid-19."To get the latest news on Halberd's exciting developments, including our ongoing disease eradication accomplishments, subscribe by submitting this form.(https://halberdcorporation.com/contact-us/)For more information please contact:William A. [email protected];[email protected]://www.halberdcorporation.comTwitter:@HalberdCAbout Halberd Corporation.Halberd Corporation (OTC PINK:HALB), is a publicly traded company on the OTC Market, and is in full compliance with OTC Market reporting requirements. It holds the exclusive worldwide rights to several patent- and PCT-pending extracorporeal treatments for COVID-19 and other medical maladies:­­­Title Patent/ Application No. Filing DateStatus/Document*Method for Treating and Curing Covid-19 InfectionUS 62/98998103/16/2020ProvisionalPCT/US21/2254103/16/2021International PCT*Method for Treating C...